Index of medicine substances

Inactivated trivalent poliomyelitis vaccine  •  Antiinfectives for systemic use | Viral vaccines | Poliomyelitis vaccines (J07BF03)

Inavolisib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Phosphatidylinositol-3-kinase (PI3K) inhibitors (L01EM06)

Inclisiran  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents (C10AX16)

Indacaterol  •  Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists (R03AC18)

Indacaterol + glycopyronium  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL04)

Indacaterol + glycopyrronium bromide + mometasone  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL12)

Indacaterol + mometasone  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK14)

Indapamide  •  Cardiovascular system | Low-ceiling diuretics, excluding thiazides | Sulfonamides, plain (C03BA11)

Indapamide + amlodipine  •  Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics (C08GA02)

Indinavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE02)

Indocyanine green  •  Various | Other diagnostic agents (V04CX01)

Indomethacin  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances (M01AB01)

Infliximab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors (L04AB02)

Ingenoli mebutat  •  Dermatologicals | Chemotherapeutics for topical use | Other chemotherapeutics (D06BX02)

Inosine  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX05)

Inotersen  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX15)

Inotuzumab ozogamycin  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd22 (clusters of differentiation 22) inhibitors (L01FB01)

Insulin aspart  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, fast-acting (A10AB05)

Insulin degludec  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting (A10AE06)

Insulin degludec + insulin aspart  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting (A10AD06)

Insulin degludec + liraglutide  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting (A10AE56)

Insulin detemir  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting (A10AE05)

Insulin glargine  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting (A10AE04)

Insulin glargine + lixisenatide  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting (A10AE54)

Insulin glulisine  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, fast-acting (A10AB06)

Insulin lispro  •  Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting (A10AD04)

Interferon alfa (HuIFN-alfa-Le)  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB01)

Interferon alfa 2A  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB04)

Interferon alfa 2B  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB05)

Interferon alfacon-1  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB09)